GlassScriptPhysician profile
Amy Jo Kump
NPI 1689632887
$980.28
in general payments reported to CMS, 2019-2025
18 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.79 · 2022: $138 · 2023: $238 · 2024: $335 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $253.42 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $74.13 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $66.52 | 2022-2024 | Breztri, Airsupra |
| Amgen INC. | $63.02 | 2023-2025 | Repatha, Otezla, Repatha |
| E.R. Squibb & Sons, L.L.C. | $60.35 | 2023-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $55.66 | 2023-2024 | Xarelto |
| Phathom Pharmaceuticals, INC. | $54.77 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $54.25 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.04 | 2022-2025 | Jardiance, Tradjenta |
| Lilly USA, LLC | $45.31 | 2023-2025 | Mounjaro |
| Pfizer INC. | $39.60 | 2025 | |
| Glaxosmithkline, LLC. | $30.96 | 2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Dexcom, INC. | $29.74 | 2023-2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $26.02 | 2025 | Cologuard Collection Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.40 | 2024 | Lifevest |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $21.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.09 | 2022 | |
| Abbott Laboratories | $16.91 | 2024 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Kump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.